MedTrace Logo

High-risk Influenza Vaccine Alert

NCT05492786 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80452

Last updated 2024-12-30

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to assess, prospectively, the effect on flu vaccination rates of salient alerts in the electronic health record that indicate a patient's high risk for flu and its complications. The investigators hypothesize that the salient alerts will lead to increased flu vaccination compared with a standard flu alert.

Conditions

Interventions

BEHAVIORAL

Alert

Non-interruptive best practice alert in the electronic health record

BEHAVIORAL

Salient alert features

Larger alert header and body font size, use of different font colors and boldface

BEHAVIORAL

High-risk Text

Alert header indicates patient is at high risk for flu and its complications; alert body indicates the percentage of risk (e.g., in the top 3% of risk)

BEHAVIORAL

Risk factors

Alert body indicates the top 3 factors contributing to the high risk

Sponsors & Collaborators

  • Massachusetts Institute of Technology

    collaborator OTHER

  • National Institute on Aging (NIA)

    collaborator NIH

  • National Bureau of Economic Research, Inc.

    collaborator OTHER

  • Geisinger Clinic

    lead OTHER

Principal Investigators

  • Christopher F Chabris, PhD · Geisinger Clinic

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-09-01
Primary Completion
2023-04-01
Completion
2023-04-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05492786 on ClinicalTrials.gov